drugset / Trial / NCT06411925

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

NCT06411925

Phase 4 Recruiting 296 enrolled SamA Pharmaceutical Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients

Timeline

Start
2023-11-10
Primary completion
2027-07
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atock Dry Syrup Unknown
Comparator Tulobuterol Small molecule

Indications